Inhibitory effect of cholestyramine on the absorption of flufenamie and mefenamic acids in rats.
D000284:Administration, Oral; D000818:Animals; D001665:Binding Sites; D002792:Cholestyramine Resin / Q000008:administration & dosage / Q000494:pharmacology*; D004347:Drug Interactions; D005439:Flufenamic Acid / Q000627:therapeutic use; D006000:Glycocholic Acid / Q000378:metabolism; D066298:In Vitro Techniques; D007408:Intestinal Absorption / Q000187:drug effects*; D008297:Male; D008528:Mefenamic Acid / Q000627:therapeutic use; D051381:Rats; D013656:Taurocholic Acid / Q000378:metabolism
D002792:Cholestyramine Resin; D008528:Mefenamic Acid; D013656:Taurocholic Acid; D005439:Flufenamic Acid; D006000:Glycocholic Acid